United Therapeutics Announces FDA Approval Of Third Generation Nebulizer For The Tyvaso® Inhalation System
Go back to United Therapeutics Announces FDA Approval Of Third Generation Nebulizer For The Tyvaso® Inhalation System| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 541.83 -3.09 (0.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $544.92 | 52 Week High | $164.04 | |||
| Open | $547.42 | 52 Week Low | $97.52 | |||
| Day High | $552.46 | P/E | 99.05 | |||
| Day Low | $535.63 | EPS | $5.47 | |||
| Volume | 550,841 | |||||
